Ovid Therapeutics OverviewOvid Therapeutics Net Income
Profitability analysis for OVID.
Quarterly Net Income
-$16.99M
↓ 65.98% YoY
As of Mar 2026
Annual Net Income (TTM)
-$24.17M
↑ 3.23% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...